rs368611522
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000617875.6(RECQL4):c.2467G>A(p.Glu823Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,555,340 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E823G) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000617875.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2467G>A | p.Glu823Lys | missense_variant | 15/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2467G>A | p.Glu823Lys | missense_variant | 15/21 | 1 | NM_004260.4 | ENSP00000482313 | P1 | |
RECQL4 | ENST00000621189.4 | c.1396G>A | p.Glu466Lys | missense_variant | 14/20 | 1 | ENSP00000483145 | |||
ENST00000580385.1 | n.271+298C>T | intron_variant, non_coding_transcript_variant | 3 | |||||||
RECQL4 | ENST00000534626.6 | c.640G>A | p.Glu214Lys | missense_variant | 6/8 | 5 | ENSP00000477457 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 22AN: 146134Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000213 AC: 43AN: 201436Hom.: 1 AF XY: 0.000202 AC XY: 22AN XY: 108886
GnomAD4 exome AF: 0.000144 AC: 203AN: 1409108Hom.: 2 Cov.: 66 AF XY: 0.000144 AC XY: 100AN XY: 694024
GnomAD4 genome AF: 0.000150 AC: 22AN: 146232Hom.: 0 Cov.: 34 AF XY: 0.000156 AC XY: 11AN XY: 70694
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 09, 2021 | DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.2467G>A, in exon 15 that results in an amino acid change, p.Glu823Lys. This sequence change has been described in the gnomAD database with a frequency of 0.25% in the Ashkenazi Jewish subpopulation (dbSNP rs368611522). The p.Glu823Lys change affects a moderately conserved amino acid residue located in a domain of the RECQL4 protein that is not known to be functional. The p.Glu823Lys substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD). This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Glu823Lys change remains unknown at this time. - |
Rothmund-Thomson syndrome type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | May 17, 2024 | The RECQL4 c.2467G>A (p.Glu823Lys) missense change has a maximum subpopulation frequency of 0.032% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function, but to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. - |
RECQL4-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 20, 2024 | The RECQL4 c.2467G>A variant is predicted to result in the amino acid substitution p.Glu823Lys. This variant was identified in a healthy individual in a study of cancer susceptibility genes (Table S1. Bodian et al. 2014. PubMed ID: 24728327). This variant is reported in 0.25% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygote. This variant is listed in ClinVar with conflicting interpretations of uncertain, likely benign, and benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/135141/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Jun 23, 2021 | - - |
Baller-Gerold syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at